{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:04:20Z","timestamp":1777637060514,"version":"3.51.4"},"reference-count":21,"publisher":"Wiley","issue":"5-6","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":10899,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1983,5,6]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Enalapril (MK\u2010421) is a new angiotensin converting enzyme inhibitor which effectively lowers elevated blood pressure and might also be useful in heart failure. Enalapril was infused into six awake dogs 2 hours after left circumflex coronary artery embolization (acute failure group) and into six other awake dogs two to six months after coronary embolization (chronic failure group). In the acute failure group 2 hours after embolization, increased left ventricular end\u2010diastolic pressure and reduced cardiac output remained unchanged during enalapril infusion. In the chronic failure group, increased left ventricular end\u2010diastolic pressure also remained unchanged during enalapril infusion, but cardiac output, which had fallen to 131.8 \u00b1 11.9 (S.D.) from 165.8 \u00b1 17.9 ml\/min\/kg (<jats:italic>P<\/jats:italic> &lt; 0.01) by two to six months in this group rose during enalapril infusion to 154.5 \u00b1 27.7 ml\/min\/kg (<jats:italic>P<\/jats:italic> &lt; 0.05). Heart rate and blood pressure were not changed during enalapril in either group, but stroke volume rose (26.0 \u00b1 5.9 to 29.2 \u00b1 6.9 ml, <jats:italic>P<\/jats:italic> &lt; 0.01) and systemic vascular resistance fell (58.5 \u00b1 10.3 to 39.3 \u00b1 4.3 units, <jats:italic>P<\/jats:italic> &lt; 0.01) during enalapril only in the chronic failure group. Plasma renin activity after embolization was slightly but not significantly higher in the acute failure group. Thus, enalapril appears to be an arterial vasodilator in dogs with chronic but not acute left ventricular failure.<\/jats:p>","DOI":"10.1002\/j.1552-4604.1983.tb02725.x","type":"journal-article","created":{"date-parts":[[2013,3,9]],"date-time":"2013-03-09T00:56:46Z","timestamp":1362790606000},"page":"189-198","source":"Crossref","is-referenced-by-count":9,"title":["Effects of a New Angiotensin Converting Enzyme Inhibitor, Enalapril, in Acute and Chronic Left Ventricular Failure in Dogs"],"prefix":"10.1002","volume":"23","author":[{"given":"CHERYL L.","family":"LEDDY","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARY","family":"WILEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOSEPH A.","family":"FRANCIOSA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)90937-5"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1982.125"},{"key":"e_1_2_1_4_2","first-page":"552","article-title":"Antihypertensive activity of N\u2010[(S)\u20101\u2010carboxy\u20103\u2010phenylproply]\u2010L\u2010Ala\u2010L\u2010Pro and its ethyl ester (MK\u2010421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo","volume":"216","author":"Gross DM","year":"1981","journal-title":"J Pharmacol Exp Therap."},{"key":"e_1_2_1_5_2","first-page":"167","article-title":"Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK\u2010421 and captopril in spontaneous and renal hypertensive rats","volume":"76","author":"Sweet CS","year":"1981","journal-title":"J Pharmacol."},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(82)90364-2"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.58.5.763"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197907193010301"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.62.1.35"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1972.34"},{"key":"e_1_2_1_11_2","first-page":"177","article-title":"Systemic and regional hemodynamics after coronary embolization in closed chest dogs","volume":"1","author":"Franciosa JA","year":"1974","journal-title":"Circ Shock."},{"key":"e_1_2_1_12_2","first-page":"213","article-title":"Importance of state of consciousness in determining hemodynamic responses to acute coronary occlusion in the dog","volume":"4","author":"Franciosa JA","year":"1977","journal-title":"Circ Shock."},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/12.5.294"},{"key":"e_1_2_1_14_2","first-page":"H477","article-title":"Progressive myocardial dysfunction associated with increased vascular resistance","volume":"239","author":"Franciosa JA","year":"1980","journal-title":"Am J Physiol."},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(81)90131-9"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.82.1.64"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0410419"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.65.1.40"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(79)90238-8"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(82)90243-0"},{"key":"e_1_2_1_21_2","first-page":"219A","article-title":"Lack of hemodynamic effects of lowering circulating norepinephrine in patients with congestive heart failure (Abstr.)","volume":"30","author":"Schwartz DE","year":"1982","journal-title":"Clin Res."},{"key":"e_1_2_1_22_2","first-page":"H554","article-title":"Renal effects of left atrial distension in dogs with chronic congestive heart failure","volume":"236","author":"Zucker IH","year":"1979","journal-title":"Am J Physiol."}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1552-4604.1983.tb02725.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1552-4604.1983.tb02725.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T08:02:49Z","timestamp":1693468969000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/j.1552-4604.1983.tb02725.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,5,6]]},"references-count":21,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[1983,5,6]]}},"alternative-id":["10.1002\/j.1552-4604.1983.tb02725.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1552-4604.1983.tb02725.x","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,5,6]]}}}